Common OTC Drug Linked to High Anemia Risk in Seniors

Aspirin, a small, unassuming white pill, has long been a fixture in many medicine cabinets, revered for its potential to prevent heart disease. For decades, it was recommended by doctors as a daily ritual for older adults seeking a simple and low-cost method to protect their cardiovascular health. However, as research evolves, so too does our understanding of its effects on the body. Recent findings suggest that while aspirin’s benefits are well-known, its risks, particularly the increased risk of anemia in seniors, have become a significant concern.¹

Understanding Anemia and Its Impact on Seniors

Anemia, according to the National Institutes of Health, is a condition marked by a deficiency of healthy red blood cells, which reduces the body’s ability to transport oxygen to tissues effectively. This lack of oxygen can lead to symptoms like fatigue, breathlessness, and dizziness. In older adults, these symptoms can significantly impact their quality of life, leading to further complications such as decreased physical activity and increased vulnerability to other health issues. The Centers for Disease Control and Prevention (CDC) reports that roughly 3 million Americans suffer from anemia, underlining its prevalence as a serious public health issue.

The ASPREE Study and Its Revelations

The ASPREE (ASPirin in Reducing Events in the Elderly) study, a large-scale initiative conducted across Australia and the United States, recently examined the impact of aspirin on older adults. The study focused on individuals aged 70 and above (or 65 for Black and Hispanic individuals), splitting them into two groups: one receiving a daily 100 mg dose of aspirin and the other a placebo. The researchers monitored these groups to identify any differences in the onset of anemia, as well as changes in hemoglobin concentrations and serum ferritin levels.

The findings were telling. Those taking aspirin experienced a 20% higher risk of developing anemia compared to the placebo group. Specifically, the aspirin group recorded 51.2 anemia incidents per 1,000 person-years, significantly higher than the 42.9 incidents seen in the placebo group. Moreover, aspirin users showed a pronounced decline in hemoglobin—a protein crucial for oxygen transport in the body—as well as a sharper drop in ferritin levels, which indicates a decrease in iron stores.

Read More: If You’ve Suffered a Heart Attack, Has Your Doctor Checked On This One Important Thing?

Expert Opinions on Aspirin and Anemia

Dr. John D. Bisognano, a clinical professor of medicine and director of General, Consultative, and Preventive Cardiology at the University of Michigan, weighed in on these findings, emphasizing the overlooked risks of anemia associated with aspirin use in older adults. “While the risk of bleeding from aspirin use is well-known, the concern of anemia, especially among older adults, has been largely overlooked,” Dr. Bisognano stated. He highlighted that beyond its well-documented potential to cause significant bleeding, aspirin might also contribute to anemia, a condition that can further exacerbate functional decline and psychological impacts like depression in seniors.

Dr. Bisognano advised a cautious approach to prescribing aspirin to older adults, suggesting that physicians should reevaluate its routine use, especially when the risks outweigh the potential cardiovascular benefits. For those seniors who may still benefit from aspirin, he stressed the importance of close monitoring for signs of anemia and reduced ferritin levels to ensure their overall well-being.

Polypharmacy and Its Complications in Seniors

The problem of polypharmacy, where patients take multiple medications simultaneously, is especially prevalent in older adults. A study focusing on patients with atrial fibrillation (AF) in New South Wales, Australia, revealed that 94.8% of these individuals used five or more medications, and over half took ten or more.² The study showed that the extensive use of drugs, especially antithrombotics like aspirin, increases the risk of adverse drug interactions and complications.

Older AF patients who were on multiple medications were often those with lower bleeding risks, making them more likely to be prescribed high-risk antithrombotics. The frequent combination of such medications can lead to a higher probability of medication misadventures, including anemia, due to the complex interactions between these drugs.

Read More: Many Older Adults Are Taking Daily Aspirin When They Shouldn’t Be, Experts Say

Medication Complexity in Heart Failure Patients

The issue of polypharmacy extends beyond AF patients to those suffering from heart failure as well. Research examining the complexity of medication regimens in older adults with heart failure found that many patients, particularly those with ischemic cardiomyopathy, had higher medication counts and scores, indicating a complex and burdensome drug regimen.³ The study highlighted that 72% of these patients were taking eleven or more medications, with a significant portion involving over-the-counter drugs like aspirin.

This high level of medication complexity often leads to lower adherence rates, which can negatively impact clinical outcomes in these patients. Addressing the complexities of medication regimens for older adults could potentially reduce the risks associated with polypharmacy, including the increased incidence of anemia.

Rethinking Aspirin Use in Seniors

Given the recent evidence linking aspirin use to a higher risk of anemia, it may be time for healthcare providers to reassess its role in preventive care for older adults. Dr. Bisognano’s suggestion to closely monitor those who continue to take aspirin underlines the importance of personalized medicine in managing the health of seniors. Regular blood tests to track hemoglobin and ferritin levels should become a routine part of care for older adults on aspirin therapy.

Furthermore, reducing polypharmacy by carefully evaluating each patient’s medication list could help mitigate the risks of adverse drug interactions and improve their overall health outcomes. Seniors and their caregivers should be proactive in discussing the necessity and safety of their medications with their healthcare providers to ensure they are taking the safest and most effective treatments available.

Conclusion

The growing body of research on the risks associated with aspirin use in older adults paints a clearer picture of its potential dangers, particularly regarding anemia. While aspirin has long been celebrated for its cardiovascular benefits, these new findings suggest a need for a more cautious approach in its prescription. Balancing its preventive benefits against the risk of anemia and other complications requires careful consideration by both doctors and patients. With ongoing studies and increased awareness, the medical community is better equipped to make informed decisions about the role of aspirin in senior care.

Read More: Daily Low-dose aspirin linked to bleeding in the skull, report says